Evidence map›Paper›PMID 32211349›Full record

Observational studyCanadian journal of gastroenterology & hepatology2020

Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.

Kelsey Ragan, Anjali Pandya, Tristan Holotnak, Katrina Koger, Neil Collins, Mark G Swain

Abstract readObservational Study
In one paragraph

Observational study in Canadian journal of gastroenterology & hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kelsey RaganDepartment of Emergency Medicine, University of Calgary, Calgary, AB, Canada.ORCID 0000-0002-7457-7369
Anjali PandyaDepartment of Emergency Medicine, University of Calgary, Calgary, AB, Canada.
Tristan HolotnakCumming School of Medicine, University of Calgary, Calgary, AB, Canada.ORCID 0000-0003-1659-7027
Katrina KogerDepartment of Emergency Medicine, University of Calgary, Calgary, AB, Canada.
Neil CollinsDepartment of Emergency Medicine, University of Calgary, Calgary, AB, Canada.
Mark G SwainDivision of Gastroenterology, Department of Medicine, University of Calgary, Calgary, AB, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Approximately 0.7% of the Canadian population is infected with hepatitis C virus (HCV), and many individuals are unaware of their infection. Our objectives were to utilize an emergency department (ED) based point-of-care (POC) HCV screening test to describe our local population and estimate the proportion of high-risk patients in our population with undiagnosed HCV. Methods: A convenience sample of medically stable patients (≥18 years) presenting to a community ED in Calgary, AB, between April and July 2018 underwent rapid clinical screening for HCV risk factors, including history of injection drug use, healthcare in endemic countries, and other recognized criteria. High-risk patients were offered POC HCV testing. Antibody-positive patients underwent HCV-RNA testing and were linked to hepatology care. The primary outcome was the proportion of new HCV diagnoses in the high-risk population. Results: Of the 999 patients screened by survey, 247 patients (24.7%) were high-risk and eligible for testing. Of these, 123 (49.8%) were from HCV-endemic countries, while 63 (25.5%) and 31 (12.6%) patients endorsed a history of incarceration and intravenous drug use (IVDU), respectively. A total of 144 (58.3%) eligible patients agreed to testing. Of these, 6 patients were POC-positive (4.2%, CI 0.9-7.4%); all 6 had antibodies detected on confirmatory lab testing and 4 had detectable HCV-RNA viral loads in follow-up. Notably, 103 (41.7%) patients declined POC testing.

Indexed as

Point-of-Care TestingCanadaEmergency Service, HospitalFemaleHepacivirusHepatitis CHepatitis C AntibodiesHumansMaleMass ScreeningMiddle AgedPilot ProjectsRisk FactorsRNA, ViralSerologic TestsSubstance Abuse, IntravenousHepatitis C AntibodiesRNA, Viral

Identifiers

PMID32211349
PMCPMC7049435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.